VACUETTE TUBE 4 ml FX Sodium Fluoride/Potassium Oxalate, Item #454297, 13x75 grey cap-black ring, non-ridged.
Published January 24, 2024 · Recall initiated: December 12, 2023
Summary
FDA records medical device Class II recall Z-0733-2024, published January 24, 2024 and initiated December 12, 2023. Recalling firm: Greiner Bio-One North America, Inc.; Status: Ongoing; Reported quantity: 495,600 tubes; Lot: Lot #A221135N, Exp. date 03/02/2024, UDI-DI Case label 39120017575130, UDI Rack label 29120017575133. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Tubes have missing additive/anticoagulant resulting in clotting in most cases. A completely clotted sample would lead to no results being reported, which could lead to a delay in treatment or diagnosis. An erroneous glucose or lactose result from a partially clotted sample could lead to inappropriate treatment.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Greiner Bio-One North America, Inc.
- Distributor
- US Nationwide distribution in the states of CT, FL, IA, IL, MO, NC, NY, PA, TN, and VA.
- Lot
- Lot #A221135N, Exp. date 03/02/2024, UDI-DI Case label 39120017575130, UDI Rack label 29120017575133.
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDABrand Name: VACUETTE Product Name: LH Lithium Heparin Separator Model/Catalog Number: 454008P ProductOctober 28, 2026
- FDAVACUETTE® TUBE 8 ml CAT Serum Separator Clot Activator 16x100 red cap-yellow ring, non-ridgedJuly 24, 2024
- FDA(1) CareEvent, Model No. 866435 (2) CareEvent Upgrade, Model no. 866436January 24, 2024
- FDAFreeStyle Libre 3 App, part of Continuous Glucose Monitoring System, when used on the Android 13 OperatingJanuary 24, 2024
- FDAgreiner bio-one VACUETTE TUBE, 5 ml LH Lithium Heparin Sep, 13x100 green cap-yellow ring, non-ridged, 24 racksJanuary 26, 2022
- FDAVACUETTE Tube 2ml 9NC Coagulation Sodium Citrate 3.2%. Item no. 454322. Lot no. B1908355.April 22, 2020
Questions about this recall
Was VACUETTE TUBE 4 ml FX Sodium Fluoride/Potassium Oxalate, Item #454297, 13x75 grey cap-black ring, non-ridged. recalled?
Yes. FDA published recall Z-0733-2024 on January 24, 2024. Reported hazard: Tubes have missing additive/anticoagulant resulting in clotting in most cases. A completely clotted sample would lead to no results being reported, which could lead to a delay in treatment or diagnosis. An erroneous glucose or lactose result from a partially clotted sample could lead to inappropriate treatment.
What should I do if I have this product?
Voluntary: Firm initiated · Letter